{"id":"n-acetylcysteine-intralipid-heparin","safety":{"commonSideEffects":[{"rate":null,"effect":"Nausea and vomiting (N-acetylcysteine)"},{"rate":null,"effect":"Bleeding or hemorrhage (heparin)"},{"rate":null,"effect":"Lipemia or hypertriglyceridemia (intralipid)"},{"rate":null,"effect":"Infusion-related reactions"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"N-acetylcysteine replenishes glutathione and reduces oxidative stress; intralipid provides essential fatty acids and calories for parenteral nutrition; heparin prevents thrombosis by inhibiting coagulation factors. This combination is typically used in critical care or specialized clinical settings to address multiple physiological needs simultaneously.","oneSentence":"This is a combination therapy using N-acetylcysteine as an antioxidant, intralipid as a lipid emulsion for nutritional support, and heparin as an anticoagulant.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:56:30.165Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Supportive care in critical illness or acetaminophen overdose (N-acetylcysteine component)"},{"name":"Parenteral nutrition support (intralipid component)"},{"name":"Thrombosis prevention (heparin component)"}]},"trialDetails":[{"nctId":"NCT00188773","phase":"PHASE4","title":"Mechanism of Fatty Acid-Induced Impairment of Glucose-Stimulated Insulin Secretion","status":"COMPLETED","sponsor":"University Health Network, Toronto","startDate":"2004-01","conditions":"Insulin Resistance Syndrome X, Pancreatic Beta Cell Function","enrollment":15}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":1,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"N-acetylcysteine, intralipid, heparin","genericName":"N-acetylcysteine, intralipid, heparin","companyName":"University Health Network, Toronto","companyId":"university-health-network-toronto","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This is a combination therapy using N-acetylcysteine as an antioxidant, intralipid as a lipid emulsion for nutritional support, and heparin as an anticoagulant. Used for Supportive care in critical illness or acetaminophen overdose (N-acetylcysteine component), Parenteral nutrition support (intralipid component), Thrombosis prevention (heparin component).","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}